VEGFA and neoplasm: VEGF inhibitors not only impair angiogenesis but also modulate the tumor microenvironment in a manner that reduces MDSC recruitment and function, thereby enhancing anti-tumor immune responses (Yang et al., 2025; Zhao et al., 2022b).